相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2008
Kyu-Won Jung et al.
CANCER RESEARCH AND TREATMENT (2011)
Do we have markers to select patients for adjuvant therapies of non-small-cell lung cancer?
K. Konopa
ANNALS OF ONCOLOGY (2010)
How to integrate current knowledge in selecting patients for first line in NSCLC?
E. Felip et al.
ANNALS OF ONCOLOGY (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Validation of ERCC1-XPF Immunodetection
Ken Andre Olaussen et al.
CANCER RESEARCH (2010)
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data
A. Auperin et al.
LANCET (2010)
The DNA Damage Response: Making It Safe to Play with Knives
Alberto Ciccia et al.
MOLECULAR CELL (2010)
DNA Damage Response Induced by Tobacco Smoke in Normal Human Bronchial Epithelial and A549 Pulmonary Adenocarcinoma Cells Assessed by Laser Scanning Cytometry
Hong Zhao et al.
CYTOMETRY PART A (2009)
Different Impact of Excision Repair Cross-Complementation Group 1 on Survival in Male and Female Patients With Inoperable Non-Small-Cell Lung Cancer Treated With Carboplatin and Gemcitabine
Bente Holm et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Cell cycle kinases as therapeutic targets for cancer
Silvia Lapenna et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Screening for lung cancer, an ongoing debate
P. E. Postmus
ANNALS OF ONCOLOGY (2008)
Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients
W. Jacot et al.
ANNALS OF ONCOLOGY (2008)
Lung Adjuvant Cisplatin Evaluation: A pooled analysis by the LACE collaborative group
Jean-Pierre Pignon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer
Giorgio Vittorio Scagliotti et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
Kyung-Hun Lee et al.
LUNG CANCER (2008)
DNA damage response mediators MDC1 and 53BP1:: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours
J. Bartkova et al.
ONCOGENE (2007)
Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression
Paolo Giovanni Nuciforo et al.
CARCINOGENESIS (2007)
The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours
Peter Goldstraw et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer
Zhong Zheng et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Comparison of Face-to-Face Interview Questionnaires and Medical Records Data for Smoking Habits in Lung Cancer Patients
Eui-Cheol Lee et al.
TUBERCULOSIS AND RESPIRATORY DISEASES (2007)
DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
Ken A. Olaussen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
VG Gorgoulis et al.
NATURE (2005)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
